Skip to main content
. Author manuscript; available in PMC: 2017 Apr 13.
Published in final edited form as: N Engl J Med. 2016 Oct 13;375(15):1448–1456. doi: 10.1056/NEJMoa1604330

Table 2.

Comparison of 28-Day Mortality According to Treatment Group.*

Variable Current Standard of Care Alone Current Standard of Care plus ZMapp Bayesian Estimate of Absolute Difference Bayesian Estimate of Relative Risk Posterior Probability That ZMapp Was Superior
percentage points (95% CI) value (95% CI) %
No. of patients alive 22 28

No. of patients who died 13 8

No. of patients lost to follow-up 1 0

28-Day mortality — % 37 22 −14 (−34 to 6) 0.62 (0.29 to 1.24) 91.2
*

CI denotes credible interval.

These are crude non-Bayesian estimates.